Skip to content

Clinical trials

Phase 3 Carcinoma, Renal Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 3 Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20033
20045
20054
20065
20074
20084
20093
20106
20114
20125
20131
20141
20151
20165
20179
20183
20197
20202
20218
20223
20235
20244
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Active, not recruiting20
Recruiting14
Terminated12
Unknown status5
Not yet recruiting4
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC9
National Cancer Institute (NCI)7
Bristol-Myers Squibb6
Hoffmann-La Roche5
Novartis Pharmaceuticals5
Pfizer5
Bayer4
Centre Leon Berard4
European Organisation for Research and Treatment of Cancer - EORTC4
Alliance for Clinical Trials in Oncology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell116
Kidney Neoplasms35
Neoplasms12
Neoplasm Metastasis10
Carcinoma5
Melanoma5
Breast Neoplasms4
Carcinoma, Hepatocellular4
Carcinoma, Non-Small-Cell Lung4
Prostatic Neoplasms4

Trials

Showing 26 to 50 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.